CureVac NV (CVAC)
4.48
+0.16
(+3.70%)
USD |
NASDAQ |
Dec 30, 16:00
4.48
0.00 (0.00%)
After-Hours: 05:12
CureVac EPS Diluted (Quarterly): 1.414 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioNTech SE | -0.1395 |
| Immatics NV | -0.4859 |
| Evotec SE | -0.1417 |
| InflaRx NV | -0.2115 |
| Anbio Biotechnology | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 319.28M |
| Revenue (Quarterly) | 63.26M |
| Total Expenses (Quarterly) | -256.02M |
| Enterprise Value | 561.07M |
| Gross Profit Margin (Quarterly) | 91.57% |
| Earnings Yield | 15.95% |
| Normalized Earnings Yield | 16.05 |